16-18 June
Shanghai, China
Lambda Therapeutic Research and Novum Pharmaceutical Research Services participated in CPHI China 2026, one of Asia’s leading pharmaceutical industry events.
The event provided an opportunity for our business development team to engage with pharmaceutical and biotech companies from across China and the broader APAC region. Discussions focused on biosimilars, biologics, clinical development, bioanalytical services, and integrated drug development strategies.
Throughout the event, our team connected with industry professionals, explored emerging opportunities, and exchanged perspectives on evolving trends shaping the global pharmaceutical landscape.
We thank everyone who met with the Lambda-Novum team and contributed to the valuable discussions during the event.
For inquiries related to our CRO and biologics CDMO services, please contact: Email: BD@lambda-cro.com
Varun Kapoor
Head, Business Development
